Wednesday, February 10, 2010, 5:17pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEFINANCE NEWS
    Market:       |  

Nxstage Medical, Inc. (NXTM)

At 5:00AM SGT: 7.81 USD   0.00 (0.00%)  
 MORE ON NXTM 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 NxStage Medical, Inc. (NGM:NXTM) Delayed quote dataEdit
Last Trade:7.81 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:7.81
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:9.81
Day's Range:N/A - N/A
52wk Range:1.90 - 9.25
Volume:0
Avg Vol (3m):95,884.1
Market Cap:364.70M
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
 Add NXTM to Portfolio   Download Data

 HEADLINES 
NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
PR Newswire (Wed, Feb 3)
NxStage(R) CEO and Founder to Participate in Innovator's Panel Discussion at the Liquidnet Forum: How the Healthcare Market is Curing Itself
PR Newswire (Thu, Jan 28)
NxStage Medical, Inc. Earnings Call scheduled for Thu, Feb 25
CCBN (Tue, Jan 26)
NxStage to Report Fourth Quarter and Full Year 2009 Financial Results
PR Newswire (Mon, Jan 25)
NxStage to Present at the Deutsche Bank Small and Mid Cap Conference
PR Newswire (Sat, Jan 23)
NxStage(R) Announces New Vice President and General Manager, International
PR Newswire (Tue, Jan 19)
Coverage initiated on Nxstage Medical by Rodman & Renshaw
Briefing.com (Fri, Jan 8)
ObamaCare Using PBMs As A Solution To High Health Care Costs: Which Stocks To Benefit?
Wall Street Transcript (Thu, Dec 17)
Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM)
PR Newswire (Tue, Dec 15)
ThermoGenesis names health care executive to board
AP (Fri, Dec 11)
More Headlines for NXTM...

 ANALYST 
EPS Est (next year) (Dec-09) :-0.94
EPS Est (in 2 years) (Dec-10) :-0.65
Avg Rec (current)*:1.4
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
NxStage Medical, Inc., a medical device company, engages in the development, manufacture, and marketing of products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures in the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
Latest NewsSingapore Indices